Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
20.03.26
/
50%
€28.40
Target price
20.03.27
€51.88
Performance (%)
-2.08%
Price
08:08
?
Summary
This prediction is currently active. With a performance of -2.08%, the BUY prediction by Canaccord_Genuity_Gr is trending in the wrong direction. This prediction currently runs until 20.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -3.414% | -3.414% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.52
04.08.26
04.08.26
€50.39
04.08.27
04.08.27
9.17%
08:08
08:08
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.85
28.04.23
28.04.23
€21.78
28.04.24
28.04.24
28.81%
29.04.24
29.04.24